Rasmussen MH - Search Results

1

Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH.

Miller BS, Blair JC, Rasmussen MH, Maniatis A, Mori J, Böttcher V, Kim HS, Bang RB, Polak M, Horikawa R. Miller BS, et al. Among authors: rasmussen mh. J Clin Endocrinol Metab. 2023 Nov 17;108(12):3090-3099. doi: 10.1210/clinem/dgad394. J Clin Endocrinol Metab. 2023. PMID: 37406251 Free PMC article. Clinical Trial.

2

Pegylated long-acting human growth hormone is well-tolerated in healthy subjects and possesses a potential once-weekly pharmacokinetic and pharmacodynamic treatment profile.

Rasmussen MH, Bysted BV, Anderson TW, Klitgaard T, Madsen J. Rasmussen MH, et al. J Clin Endocrinol Metab. 2010 Jul;95(7):3411-7. doi: 10.1210/jc.2009-2813. Epub 2010 Apr 28. J Clin Endocrinol Metab. 2010. PMID: 20427496 Clinical Trial.

3

Multiple doses of pegylated long-acting growth hormone are well tolerated in healthy male volunteers and possess a potential once-weekly treatment profile.

Rasmussen MH, Jensen L, Anderson TW, Klitgaard T, Madsen J. Rasmussen MH, et al. Clin Endocrinol (Oxf). 2010 Dec;73(6):769-76. doi: 10.1111/j.1365-2265.2010.03863.x. Clin Endocrinol (Oxf). 2010. PMID: 20718773 Clinical Trial.

4

Assessing the impact of growth hormone deficiency and treatment in adults: development of a new disease-specific measure.

Brod M, Højbjerre L, Adalsteinsson JE, Rasmussen MH. Brod M, et al. Among authors: rasmussen mh. J Clin Endocrinol Metab. 2014 Apr;99(4):1204-12. doi: 10.1210/jc.2013-3438. Epub 2014 Jan 17. J Clin Endocrinol Metab. 2014. PMID: 24438372

5

A reversible albumin-binding growth hormone derivative is well tolerated and possesses a potential once-weekly treatment profile.

Rasmussen MH, Olsen MW, Alifrangis L, Klim S, Suntum M. Rasmussen MH, et al. J Clin Endocrinol Metab. 2014 Oct;99(10):E1819-29. doi: 10.1210/jc.2014-1702. Epub 2014 Jul 11. J Clin Endocrinol Metab. 2014. PMID: 25013997 Clinical Trial.

6

Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency.

Rasmussen MH, Janukonyté J, Klose M, Marina D, Tanvig M, Nielsen LF, Höybye C, Andersen M, Feldt-Rasmussen U, Christiansen JS. Rasmussen MH, et al. J Clin Endocrinol Metab. 2016 Mar;101(3):988-98. doi: 10.1210/jc.2015-1991. Epub 2016 Jan 4. J Clin Endocrinol Metab. 2016. PMID: 26727076 Free PMC article. Clinical Trial.

7

Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.

Battelino T, Rasmussen MH, De Schepper J, Zuckerman-Levin N, Gucev Z, Sävendahl L; NN8640-4042 Study Group. Battelino T, et al. Among authors: rasmussen mh. Clin Endocrinol (Oxf). 2017 Oct;87(4):350-358. doi: 10.1111/cen.13409. Epub 2017 Aug 8. Clin Endocrinol (Oxf). 2017. PMID: 28656605 Clinical Trial.

8

Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.

Kildemoes RJ, Hollensen C, Biller BMK, Johannsson G, Takahashi Y, Rasmussen MH. Kildemoes RJ, et al. Among authors: rasmussen mh. Eur J Endocrinol. 2022 May 16;187(1):27-38. doi: 10.1530/EJE-21-1167. Eur J Endocrinol. 2022. PMID: 35521713 Free PMC article. Clinical Trial.

9

Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial.

Miller BS, Blair JC, Rasmussen MH, Maniatis A, Kildemoes RJ, Mori J, Polak M, Bang RB, Böttcher V, Stagi S, Horikawa R. Miller BS, et al. Among authors: rasmussen mh. J Clin Endocrinol Metab. 2022 Nov 25;107(12):3378-3388. doi: 10.1210/clinem/dgac513. J Clin Endocrinol Metab. 2022. PMID: 36062966 Free PMC article. Clinical Trial.

10

Psychometric Validation of the Growth Hormone Deficiency-Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency-Parent Treatment Burden Measure (GHD-PTB).

Brod M, Rasmussen MH, Alolga S, Beck JF, Bushnell DM, Lee KW, Maniatis A. Brod M, et al. Among authors: rasmussen mh. Pharmacoecon Open. 2023 Jan;7(1):121-138. doi: 10.1007/s41669-022-00373-z. Epub 2022 Oct 18. Pharmacoecon Open. 2023. PMID: 36255609 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters